Status:
COMPLETED
Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation
Lead Sponsor:
Ain Shams University
Conditions:
Agitated; State, Acute Reaction to Stress
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The aim of the study is to identify the role of preoperative chlorepheniramine maleate on alleviating or reducing the severity of postoperative agitation following FESS procedures.
Detailed Description
A total of 90 adult patients undergoing FESS procedure for sinusitis with postoperative nasal packing. Written informed consent will be obtained from all patients before randomization. Patients will b...
Eligibility Criteria
Inclusion
- The inclusion criteria of these patients include adult patients (age 18- 60 years), class I-II according to American society of anaesthesiologists (ASA) physical status subjected to FESS without septoplasty.
Exclusion
- Exclusion criteria include; patients below 18 years old or over 60 years old, patients with ASA physical status class III-IV, morbid obesity with BMI \> 30 kgm-2 at initial hospital visit, history of neuro-psychatric ailment or chronic use of antipsychotic drugs, severe cardiovascular disease, any coagulopathies, pregnancy, history of relevant drug allergy, any possibility of anticipated difficult intubation.
Key Trial Info
Start Date :
January 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04293081
Start Date
January 16 2019
End Date
July 30 2019
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AinShams University, Faculty of medicine
Cairo, Abbasia, Egypt, 11591